Clinical trial Recruiting at 4 sites Observational Ages 18 and up

Improving care for patients with extrapulmonary tuberculosis

Official title: A Multicentric Cohort and Biomarker Study for Improved Care of Patients with Extrapulmonary Tuberculosis

Run by University of Cologne · NCT06875336 · Data updated 2026-11-12

This study is trying to improve care for adults newly diagnosed with extrapulmonary tuberculosis by collecting their health information and samples to better understand the disease.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment150 (estimated)
SponsorUniversity of Cologne
Academic / other
Locations6 sites (Bonn and 5 other locations)
StatusRecruiting
StartedMarch 6, 2023
Main results expectedDecember 31, 2025
Study endsDecember 31, 2025
Registry record updatedMarch 13, 2025
Trial IDNCT06875336 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older who have been newly diagnosed with extrapulmonary tuberculosis.

Probably not a fit

Patients under 18 years of age or those with conditions that may interfere with study participation will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicentric observational study focuses on adult patients newly diagnosed with extrapulmonary tuberculosis (EPTB). Participants will be enrolled prospectively, and their clinical data will be collected through standardized questionnaires throughout their treatment. Additionally, body fluids such as blood and urine will be collected for biomarker analysis, which will be correlated with clinical data to enhance understanding of EPTB. A healthy control group will also be included for technical comparisons in laboratory analyses.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnostic and treatment strategies for patients with extrapulmonary tuberculosis.

How similar studies have gone: Other studies have shown success in using biomarker analysis for tuberculosis, but this specific approach focusing on extrapulmonary cases is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age ≥ 18 years
2. Isolation of Mycobacterium tuberculosis complex from a bodily secretion or tissue by

   1. PCR
   2. culture or a presumptive clinical diagnosis based on epidemiologic exposure in combination with physical findings, radiographic findings and/or histopathology
3. Patients with extrapulmonary TB

   * pleura
   * lymph nodes
   * bones and joints
   * larynx
   * pericardial
   * parotid gland
   * abdominal sites
   * kidneys
   * genitourinary tract
   * disseminated (miliary) TB
   * other than pulmonary TB
4. In the case of pulmonary and extrapulmonary involvement, the leading manifestation, clinically and radiographically, must be extrapulmonary.
5. Written informed consent provided prior to inclusion

Exclusion Criteria:

* 1\. Age \<18 years 2. Patient with any social or logistical condition which, as anticipated by the investigator, may interfere with the conduct of the study, such as incapacity to well understand the study content and procedure (in case of any language barriers, a translator may be involved), not willing to collaborate, or anticipated inability to finish study due to physical weakness 3. Dependencies towards the study team (e.g. family members, employees of the same department) 4. Pregnant women 5. Patient in custodianship or guardianship 6. Leading pulmonary manifestation 7. Solitary CNS tuberculosis Patients may take part in other clinical studies and trials, as long as there is no conflict with the inclusion or exclusion criteria of the mEX-TB study and the protocol of the other study or trial does not conflict with the means of data and sample collection and publication of this protocol.

Where it's running

  • Research Center Borstel
    Borstel, Germany
    Recruiting
  • University Hospital of Cologne
    Cologne, Germany
    Recruiting
  • University Hospital Hamburg
    Hamburg, Germany
    Recruiting
  • University Hospital Heidelberg
    Heidelberg, Germany
    Recruiting
  • University Hospital Bonn
    Bonn, Germany
    Not yet recruiting
  • University Hospital Frankfurt
    Frankfurt, Germany
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.